End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.98 CNY | -1.32% | +2.99% | +11.34% |
Business Summary
Number of employees: 8,933
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chemical Agents
52.9
%
| 7,000 | 55.4 % | 6,571 | 52.9 % | -6.13% |
APIs and Intermediates
26.2
%
| 3,138 | 24.8 % | 3,253 | 26.2 % | +3.66% |
Traditional Chinese Medicine
14.0
%
| 1,254 | 9.9 % | 1,745 | 14.0 % | +39.19% |
Diagnostic Reagents and Equipment
5.3
%
| 724 | 5.7 % | 659 | 5.3 % | -8.92% |
Biological
0.7
%
| 408 | 3.2 % | 84 | 0.7 % | -79.33% |
Other Business
0.4
%
| 42 | 0.3 % | 49 | 0.4 % | +18.26% |
Sales Materials, Processing Fees, Etc.
0.4
%
| - | - | 46 | 0.4 % | - |
Others
0.1
%
| - | - | 14 | 0.1 % | - |
Rental
0.1
%
| 7 | 0.1 % | 9 | 0.1 % | +29.96% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
87.3
%
| 10,959 | 87.5 % | 10,754 | 87.3 % | -1.86% |
Overseas
12.7
%
| 1,565 | 12.5 % | 1,571 | 12.7 % | +0.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yang Gang Tang
PSD | President | 55 | 17/18/17 |
Yan Xia Si
DFI | Director of Finance/CFO | 56 | 01/93/01 |
Maolin Wang
CHM | Chairman | 59 | 01/01/01 |
Bao Guo Zhu
CHM | Chairman | 62 | 01/02/01 |
Guo Xiang Xu
BRD | Director/Board Member | 61 | 01/07/01 |
De Sheng Tao
BRD | Director/Board Member | 60 | 01/85/01 |
De Long Ye
IRC | Investor Relations Contact | - | - |
Yu Xuan Huang
PRN | Corporate Officer/Principal | 57 | 25/18/25 |
Dai Hong Yang
PRN | Corporate Officer/Principal | 58 | 01/97/01 |
Liang Yang
SEC | Corporate Secretary | 41 | 01/11/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bao Guo Zhu
CHM | Chairman | 62 | 01/02/01 |
Qing Feng Qiu
BRD | Director/Board Member | 53 | 01/07/01 |
Hua Min Huang
BRD | Director/Board Member | 53 | 01/13/01 |
De Sheng Tao
BRD | Director/Board Member | 60 | 01/85/01 |
Guo Xiang Xu
BRD | Director/Board Member | 61 | 01/07/01 |
Xiong Yu
BRD | Director/Board Member | 63 | 01/13/01 |
Dai Hong Yang
PRN | Corporate Officer/Principal | 58 | 01/97/01 |
Yin Tang
BRD | Director/Board Member | 49 | 29/15/29 |
Yang Gang Tang
PSD | President | 55 | 17/18/17 |
Kam Wa Wong
BRD | Director/Board Member | 53 | 15/19/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 310,011,513 | 0 | 2,476,300 ( 0.7988 %) | 38.32 % |
Stock B | 1 | 619,552,203 | 356,180,843 ( 57.49 %) | 2,152,600 ( 0.3474 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
5,829,048 | 0.96% | 29,437,800 $ |
Company contact information
Livzon Pharmaceutical Group, Inc.
Headquarters Building 38 Chuangye North Road
519090, Zhuhai
+86 75 6813 5888
http://www.livzon.com.cnSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.34% | 4.34B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 000513 Stock
- Company Livzon Pharmaceutical Group Inc.